HT
CVAC

Headlands Technologies’s CureVac CVAC Stock Holding History

Headlands Technologies’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,468
Closed -$35.1K – 762
2025
Q2 		$35.1K Buy
+6,468
New +$25.7K ﹤0.01% 839
2024
Q2 		– Sell
-6,120
Closed -$18.5K – 1223
2024
Q1 		$18.5K Buy
+6,120
New +$21.5K ﹤0.01% 924

Other funds holding CVAC

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BA
Bridgewater Associates Westport, Connecticut $22.4B AUM 34.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Headlands Technologies's CVAC Position: Q3 2025 in Review

Headlands Technologies sold out of CureVac (CVAC) in Q3 2025, closing a stake of 6,468 shares — an estimated $35.1K sold.

Headlands Technologies first reported a position in CVAC in Q1 2024 and held it in 2 quarters. The position peaked at $35.1K in Q2 2025. 94 funds tracked by Wall St. Rank hold CVAC as of Q3 2025.

  • Headlands Technologies reported no remaining CureVac position as of Q3 2025 after selling out during the quarter.
  • Headlands Technologies sold 6,468 CureVac shares in Q3 2025, an estimated $35.1K.
  • Headlands Technologies first reported a position in CureVac in Q1 2024 and held it in 2 quarters.
  • Headlands Technologies's CureVac position peaked at $35.1K in Q2 2025.
  • 94 funds tracked by Wall St. Rank held CureVac as of Q3 2025.

Based on Headlands Technologies's 13F filing for Q3 2025, filed 12 Nov 2025.